Translational Neuropsychiatry Research Group

The Translational Neuropsychiatry Research Group (TREND Lab), led by PhD Ali Jawaid, investigates how environmental factors shape vulnerability to neuropsychiatric and neurodegenerative disorders across the lifespan and across generations.

Supported by ERA-Net, the European Joint Programme on Neurodegenerative Disease Research (JPND), and the National Science Centre (NCN), we apply a multimodal approach that integrates immortalized neuronal and microglial cell lines, microglia and brain organoids derived from induced pluripotent stem cells (iPSCs), transgenic and wild-type rodent models, and ethnically diverse human cohorts.

Read more

Our research focuses on uncovering the role of non-coding RNAs and metabolic dysfunction in the intergenerational transmission of trauma-induced disease risk. In parallel, we advance research on amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, and related neurodegenerative disorders, with particular emphasis on identifying novel metabolic and epigenetic pathways that drive disease progression and susceptibility.


Meet our team

Dr. Ali Jawaid

Ali currently conducts extensive research in areas such as childhood trauma, memory, neurodegenerative diseases, neuroepigenetics, and epigenetic inheritance.

Dr. Ismail Gbadamosi

Ismail uses advanced molecular biology techniques to explore the role of TDP-43 in cellular energy homeostasis in various models of ALS (amyotrophic lateral sclerosis) and FTLD (frontotemporal lobar degeneration).

Dr. Justyna Bącela

The researcher’s description is in preparation.

Magdalena Gomółka

Magdalena leads a demanding doctoral project aimed at investigating the role of microRNAs and lipid mediators in the intergenerational transmission of the consequences of childhood trauma. 

Taufik Hidayat

Beyond his administrative responsibilities, Taufik actively conducts molecular biology experiments, gaining specialized expertise in RNA biology and microglia. He also mentors young interns and students, sharing his knowledge and skills.

P4Health Employee

Marika Hildebrand–Jurczyk

Marika is the Administrative Manager of the TREND laboratory and serves as the primary liaison between the lab and the institute’s administration. She is the go-to person for everything from fixing the office heating system to finalizing long-term purchasing plans and organizing business trips and conferences.

Agata Małoburska

The researcher’s profile is being prepared.

Weronika Tomaszewska

Weronika investigates the mechanisms underlying vulnerability to childhood traumatic experiences, with a particular focus on the role of microglia.

P4Health Employee

Olga Doszyń

The researcher’s profile is being prepared.


Research & findings

Traumatic experiences, especially in childhood, are associated with negative physical and mental health outcomes in adulthood. Growing evidence suggests that behavioral and metabolic disturbances linked to childhood trauma may be transmitted across generations.

However, the precise mechanisms by which childhood trauma affects germ cells and enables intergenerational transmission of symptoms remain unclear.

This research combines parallel analyses in a mouse model exposed to early-life trauma with studies of human cohorts from Bosnia, Pakistan, and Poland. Current findings indicate a key role for metabolic factors and non-coding RNAs in transferring the effects of childhood trauma to germ cells, thereby enabling their transmission across generations.


Inside the lab

Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration (FTLD), are major causes of morbidity and mortality in older adults worldwide. They are characterized by the accumulation of toxic protein aggregates in the brain, such as amyloid and tau in AD and TDP-43 in ALS and FTLD.

Using a multimodal research approach, the TREND team has identified important links between cellular energy metabolism, TDP-43, and microglia—the brain’s immune cells responsible for clearing toxic protein deposits. Current findings suggest that targeted modulation of metabolic pathways can reduce TDP-43-related toxicity.

Additionally, metabolic interventions can enhance microglial clearance of amyloid deposits, offering potential therapeutic strategies for Alzheimer’s disease and other neurodegenerative disorders.

Read more

Adverse childhood experiences (ACEs) are among the strongest risk factors for neuropsychiatric disorders later in life. However, individuals differ considerably in their vulnerability to the long-term consequences of ACEs. This research proposes that microglia play a central role in mediating this vulnerability, while ACE-induced changes in serum lipid profiles and non-coding RNAs may alter microglial function.

Using an interdisciplinary approach, the project combines analyses of human cohort samples with in vitro models of human microglia. The findings have the potential to reduce the global health burden associated with adverse childhood experiences and improve understanding of the biological mechanisms linking early-life trauma to mental health outcomes.


Research projects

Early Metabolic Programming Affects the Hypothalamus, Leading to Eating Disorders – EMPATHY

Funding:
National Centre for Research and Development

Project Manager:
Dr. Ali Jawaid

Metabolic Basis of Vulnerability to Adverse Childhood Experiences – MUSEACE

Funding:
National Centre for Research and Development

Project Manager:
Dr. Ali Jawaid


From research to publication

Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons

Jawaid Ali, Pradeep Vishnu, Shamsi Afreen [et al.]

Neurology, 2011, vol. 77, no. 4, pp.406-407. DOI:10.1212/WNL.0b013e3182246ffb

Diabetes mellitus and dementia: Advocating an annual cognitive screening in patients with diabetes mellitus

Murthy Santosh B., Jawaid Ali, Schulz Paul E.

Journal of the American Geriatrics Society, 2008, vol. 56, no. 10, pp.1976-1977. DOI:10.1111/j.1532-5415.2008.01914.x

ALS disease onset may occur later in patients with pre-morbid diabetes mellitus

Jawaid Ali, Salamone A.R., Strutt A.M. [et al.]

European Journal of Neurology, 2010, vol. 17, no. 5, pp.733-739. DOI:10.1111/j.1468-1331.2009.02923.x